RecruitingNot applicableNCT03073343

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

Studying NON RARE IN EUROPE: Non-alcoholic fatty liver disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Southern California Institute for Research and Education
Principal Investigator
Timothy R Morgan, MD
VA Long Beach Healthcare System
Intervention
Betaine (trimethyglycine)(dietary_supplement)
Enrollment
48 enrolled
Eligibility
18-75 years · All sexes
Timeline
20132025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03073343 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Non-alcoholic fatty liver disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Non-alcoholic fatty liver disease

← Back to all trials